Michele R. Cole, PharmD, MS, is Director of Medical Managed Markets and Real-World Evidence at Sumitomo Pharma America. With over 20 years of experience, Michele has worked across small, medium and large pharmaceutical companies, making significant contributions in both domestic and global markets.
She has authored more than 40 publications on work and productivity, patient and physician perspectives on medication satisfaction, prescribing patterns, patient journeys, clinical characteristics, cost-effectiveness, budget-impact and predictive models.
Michele has presented on key topics like Prostate Cancer, Endometriosis, Multiple Sclerosis, Pulmonary Arterial Hypertension, Asthma, COPD, Allergy, In-patient cost savings measures, and payer reimbursement to healthcare reimbursement providers.
Interests: Real world evidence analysis, market access, Medicaid/Medicare, HTA reimbursement, Prostate Cancer, Endometriosis, Multiple sclerosis, Alzheimer’s disease, Pulmonary Arterial Hypertension, COPD, asthma, allergies, immunology, pain management, geriatrics.
